Serum Institute of India (SII) acquires 50 per cent stake of SCHOTT Kaisha
With this acquisition, Serum is securing its supply of high-quality pharma packaging amid rising global demand
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Schott Kaisha
SCHOTT increases global sales and earnings; India plant vital for fighting Coronavirus worldwide
The international specialty glass group SCHOTT is continuing its positive development and is setting the course for a new phase of…
SCHOTT KAISHA expands vial production capacity for COVID-19 vaccine Rs 105 cr investment
The fresh investment will increase vial production by 300 million pieces within 12 months
SCHOTT begins delivery of vials to package two billion doses of COVID-19 vaccines
SCHOTT’s 50-50 joint venture, SCHOTT KAISHA is supplying vials for COVID-19 vaccines to Serum Institute (India) and several other…
How glass vial makers are girding to boost access to COVID-19 vaccine
Leading glass packaging manufacturers in India disclose their measures to ramp up capacities and support India Pharma Inc as it…
Indian ancillary manufacturers assure uninterrupted supply of materials related to COVID-19 vaccine
In the recent past, many, globally and in India, had raised concerns about a potential shortage of ancillary supplies to…
Schott Kaisha advances towards India’s Pharma Vision 2020 with its new plant in Himachal Pradesh
Indo-German joint venture set to open its first plant in north India to cater to local clients from
pharma packaging facility…
Schott Kaisha celebrates its 25th anniversary in India
Celebrates with its partner and conducted a seminar on the latest trends and developments for the industry
Schott Kaisha recently…